HemOnc Today is set to announce its inaugural list of HemOnc Today's Next Gen Innovators, a select group of early career hematologists and oncologists.
HemOnc Today's Next Gen Innovators - nominated by members of HemOnc Today's Editorial Board and other leaders in the field - represent the next generation of hematologists and oncologists who have proven their ability to advance patient care through innovative approaches in the clinical and research settings.
HemOnc Today's Next Gen Innovators, in conjunction with Editorial Board members, will serve as expert sources to help HemOnc Today provide essential insights into trends, advances and challenges in the field.
HemOnc Today's Next Gen Innovators will be announced in the Dec. 25 issue of HemOnc Today and on the publication's online platform, Healio.com/HemOnc. Their names also will be displayed at the HemOnc Today exhibit booth (booth 2145) at the ASH Annual Meeting & Exposition, scheduled for Dec. 9-12 in Atlanta.
The list of HemOnc Today's Next Gen Innovators will be published annually in HemOnc Today. Special events for members will be announced throughout the year. To nominate an innovator who is working to advance the fields of hematology or oncology, email Editorial Director Mark Leiser at mleiser@healio.com or call him at 856.848-1000, ext. 418.
HemOnc Today strives to be the global, definitive information source for hematology and oncology professionals by delivering timely, accurate, authoritative and balanced reports on clinical issues, socioeconomic topics and industry developments, as well as presenting clinically relevant information on medical therapies.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
